Titres of IgG anti-A or -B in the serum of 64 blood group O women with an obstetrical history of possible ABO blood group incompatibility were examined. Four different 2-mercapto-ethanol (2-ME) techniques varying in time from 3-16 h were evaluated. No definite differences in anti-A or -B titres were observed. When AB substances were used, however, the anti-A or -B titres were on the average 2-3 titration steps lower than in the 2-ME techniques, if demonstrable at all. Besides agglutinating IgG anti-A or -B, haemolysins IgG anti-A or -B could be demonstrated in part of the sera. In 8 sera, the IgG and IgM fractions were separated on sephadex G-200 and treated with 2-ME and AB substances. In the IgG fraction, no definite differences in complete,incomplete and haemolysin anti-A or -B titres were found before and after treatment with 2-ME. Using AB substances, no complete anti-A or -B was found anymore, while the incomplete titres were on the average 2-3 titration steps lower. The anti-A or -B antibody activity of the IgM fraction was completely destroyed by 2-ME and AB substances. From this study we concluded that IgG anti-A or -B could be determined by 2-ME within a few hours and that this technique is much more reliable than the partial neutralization test with AB substances.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.